Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can visual cues unlock sentence building in children with language delays?

NCT ID NCT07786545

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This pilot study tests a new therapy called Syntactic-Semantic Visual Configuration Intervention (SSVCI) for Urdu-speaking children aged 6 to 12 who struggle to form phrases and sentences. The therapy uses visual cues and structured activities to help children understand and produce language, moving from basic concepts to early grammar. Researchers will compare 10 children with language impairment (including those with autism, hearing loss, cerebral palsy, or Down syndrome) against 10 typically developing children, measuring changes in storytelling and sentence length. The goal is to see if the therapy is practical and culturally appropriate before testing it in a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Syntactic-Semantic Visual Configuration Intervention (SSVCI), a structured, therapist-delivered language therapy using visual cues to teach sentence formation
What this could lead to
If successful, this could lead to a culturally tailored language therapy that helps children with language impairments speak in longer, more complex sentences.
What could go wrong
This is a small pilot study with only 20 children, so results may not apply broadly. The intervention is new and may need adjustments before larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both genders will be included * Children of age range 6-12 years. * Children whose primary Language is Urdu. * Children who have the concept of noun, verbs, adjectives and prepositional concepts. * Children who are unable to join them to form phrases and sentences. * Diagnosed cases of ASD, hearing impairments, Cerebral Palsy and Down syndrome. Exclusion Criteria: * Children with any co morbid conditions. * Children with Behavioral issues. * Children with attention deficit hyper activity. * Hearing impaired children not using amplifying and assistive devices. * Children with impaired vision. * Children not able to perform on ICW level 1 and blank level

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder cerebral palsy Down syndrome hearing loss disorder language disorder specific language impairment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism Down syndrome Hearing impaired children Language impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Child Development Center

    Rawalpindi, Federal, 44000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.